Suprefort is the pancreas peptide bioregulator, a capsule built around the A-1 peptide complex extracted from pancreatic tissue and studied for supporting normal pancreatic function. Its research story runs through a specific four-amino-acid sequence, KEDW, which scientists found hiding inside the insulin-signaling proteins the pancreas already makes.
That’s an unusually concrete origin for a peptide supplement. Most bioregulators are described in general terms; this one traces back to a sequence someone deliberately went looking for.
Key Takeaways
The Short Version
Suprefort is a pancreas-derived peptide bioregulator studied for supporting normal pancreatic function and healthy metabolic aging.
The pancreas runs two separate operations, blood sugar signaling and digestive enzyme production, and both change with age.
The peptide research centers on KEDW, a four-amino-acid sequence shared by insulin-signaling proteins, studied in animal models for its effect on insulin synthesis.
Anyone taking diabetes medication should coordinate with a clinician before adding a pancreas peptide, since blood sugar support can stack.
One Organ, Two Completely Different Jobs
The pancreas is really two organs sharing an address. One half handles hormones, the other half handles digestion, and they answer to different biology.
| Endocrine pancreas | Exocrine pancreas | |
|---|---|---|
| What it makes | Insulin, glucagon, other hormones | Digestive enzymes for fat, protein and starch |
| Where it goes | Straight into the bloodstream | Into the small intestine |
| Share of the organ | Roughly 2 percent of tissue | Nearly all the rest |
| What people talk about | Constantly | Almost never |
Most metabolic supplements aim exclusively at the first column. Blood sugar, insulin sensitivity, glucose response. That’s a real target, and it’s worth supporting.
But it leaves the larger half of the organ out of the conversation entirely, and that half has its own aging curve.
The Digestive Half Fades Quietly
Pancreatic volume peaks between the ages of 20 and 60, then declines, and that decline brings reduced blood flow, fibrosis and tissue atrophy along with it [1].
The functional consequence shows up in numbers most people have never seen. A systematic review in the Journal of Internal Medicine reported that 5 percent of people over 70, and 10 percent of people over 80, have measurable pancreatic exocrine insufficiency, even without any diagnosed gastrointestinal disease [1].
A population study of nearly a thousand German adults aged 50 to 75 found signs of exocrine insufficiency in 11.5 percent of participants, with a clear increase as age went up [2].
Symptoms tend to be vague enough that people write them off: bloating, loose stools, discomfort after fatty meals, gradual weight change [1]. Over time, reduced enzyme output can also affect absorption of the fat-soluble vitamins, which is why researchers connect pancreatic function to bone density and broader nutritional status [1].
The endocrine half ages too. In research on aged mouse islets, declining NAD kinase expression was linked to a weaker glucose-stimulated insulin response, one of several molecular routes by which insulin secretion capacity drops with age [3].
So the case for a pancreas-specific peptide is straightforward. Both halves of the organ change, and almost nothing in the supplement aisle is aimed at the organ as a whole.
KEDW, and How Researchers Found It
The most interesting part of the Suprefort story is a piece of sequence detective work.
Researchers compared the amino acid sequences of insulinotropic polypeptides, the proteins involved in signaling insulin production, and noticed that they shared a common four-residue fragment. They synthesized that fragment as a standalone tetrapeptide, KEDW, engineered to survive digestive proteinases [4].
Then they tested it. In research on rats with chemically induced diabetes, the tetrapeptide partially restored insulin synthesis, and the animals’ sugar curves tracked close to those of healthy controls [4]. The proposed mechanism is direct: the peptide appears to activate the preproinsulin gene promoter by binding complementary nucleotide sequences on double-stranded DNA [4].
That’s animal research, and it deserves to be labeled as such. But it’s mechanistically specific in a way most supplement ingredient stories never get.
Follow-up work pointed the same direction. KEDW was later characterized as an endogenous tetrapeptide and assessed for biological activity across development and in a model of accelerated aging [5]. A separate rat study on the tetrapeptide pancragene reported regulatory effects on both the morphology and the function of pancreatic tissue [6]. And a broader review of peptide-driven cell differentiation identified KEDW specifically as a peptide that induces pancreatic cell differentiation, alongside AEDL for lung tissue [7].
The wider mechanism behind the whole bioregulator family holds up in mainstream journals as well. Short peptides of two to seven amino acids can enter the cell nucleus, interact with DNA and histone proteins, and influence which genes are transcribed [8]. Decades of research on peptide bioregulators reported that long-term treatment slowed age-related changes in biomarkers of aging, with clinical applications tracked across six to twelve years [9].
If the category itself is new to you, our explainer on how peptide bioregulators are grouped by organ system covers the fundamentals, and the history of the Khavinson peptide program explains where these compounds originated.
What Suprefort Is Built to Do, Stated Plainly
Suprefort is designed to support normal pancreatic function and healthy metabolic aging as part of a daily routine. It’s a peptide complex, not a hormone and not an enzyme replacement.
Here’s the honest boundary. Suprefort does not treat, manage or reverse diabetes, and it is not a substitute for prescribed medication or for pancreatic enzyme therapy. The studies above were run in animal models of induced diabetes, which is a research tool, not a claim about what a capsule does in a person.
What it offers instead is tissue-specific support for an organ that most longevity routines never address directly.
One safety point that genuinely matters: if you take insulin, metformin, a sulfonylurea, or a GLP-1 medication, talk to your clinician before adding Suprefort. Support aimed at blood sugar can stack with medication aimed at the same target, and that’s a conversation worth having in advance rather than after.
Building It Into a Metabolic Routine
Suprefort works best as one component of a metabolic routine rather than the whole plan. Diet composition, meal timing, training and sleep still carry the most weight, and the peptide is designed to support that foundation.
Each BioPancreas capsule delivers 40 mg of the A-1 peptide complex. Bioregulators are taken in courses rather than continuously, and the typical protocol is one to two capsules with meals for a 30-day course, repeated a few times a year. Follow the product label unless your clinician advises otherwise.
It tends to suit a few kinds of people:
- Adults over 45 focused on metabolic aging who already have the fundamentals handled.
- Bioregulator users adding pancreatic support to an organ-system stack.
- People who notice digestive sluggishness after richer meals and want organ-level support rather than another enzyme blend.
Because the pancreas and liver work the same digestive shift, many people run it alongside BioLiver (Svetinorm). If you’re assembling a broader stack, the full peptide bioregulator range is organized by organ, and the metabolic support collection groups formulas by goal instead.
Sourcing, Purity, and the Paperwork That Should Come With It
Pancreas peptide complexes are animal-tissue derived, which puts sourcing and verification at the center of the buying decision rather than the edge of it.
Three things are worth confirming before you order:
- A Certificate of Analysis from an independent lab, published where you can actually read it.
- Analytical confirmation of identity and purity, ideally HPLC with UV detection coupled to mass spectrometry.
- A transparent label listing the exact peptide complex and the milligram amount per capsule.
BioLongevity publishes Certificates of Analysis for every batch, verified through an independent CLIA-certified facility, with purity confirmed at 98 percent or higher. For an ingredient this specialized, that paperwork is the product.
Frequently Asked Questions
What is Suprefort used for?
Suprefort is used to support normal pancreatic function and healthy metabolic aging. It’s taken as part of a longevity or metabolic routine, not as a treatment for any condition.
Is Suprefort the same as Pancragen?
They’re related but not identical. Suprefort is the natural A-1 peptide complex extracted from pancreatic tissue. Pancragen is the synthesized KEDW tetrapeptide studied as a research compound. Suprefort is the form used in bioregulator supplements.
Can Suprefort be taken with diabetes medication?
Talk to your clinician first. Suprefort is not a replacement for prescribed medication, and support aimed at blood sugar can stack with drugs aimed at the same target.
Does Suprefort contain digestive enzymes?
No. Suprefort is a peptide complex, not an enzyme supplement. If you need pancreatic enzyme replacement, that’s a clinical decision and a different product category.
How long is a Suprefort course?
A typical course runs 30 days, with one to two capsules taken with meals, repeated a few times per year. Follow the product label for the exact protocol.
Can Suprefort be combined with other bioregulators?
Yes. Bioregulators are routinely stacked across organ systems, and the pancreas complex is commonly paired with liver or gut-focused formulas.
Read More From the BioLongevity Blog
- Berberine vs. Metformin: What the Research Shows
- AMPK Activation Supplements: How the Pathway Works
- Glandokort Peptide Benefits: The Adrenal Bioregulator
Ready to give the pancreas the same attention your routine already gives the liver and the gut? BioPancreas – A-1 Pancreas Peptide Bioregulator (Suprefort) delivers a transparent 40 mg A-1 peptide complex, third-party tested at 98 percent purity or higher, with the Certificate of Analysis published before you buy.
Ask a qualified clinician before starting any supplement if you are pregnant, nursing, taking medication, or managing a medical condition.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
- Löhr JM, Panic N, Vujasinovic M, Verbeke CS. The ageing pancreas: a systematic review of the evidence and analysis of the consequences. Journal of Internal Medicine. 2018;283(5):446-460. https://doi.org/10.1111/joim.12745
- Rothenbacher D, Löw M, Hardt PD, Klör HU, Ziegler H, Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scandinavian Journal of Gastroenterology. 2005;40(6):697-704. https://doi.org/10.1080/00365520510023116
- Li GJ, Cheng ML, Lin YT, Ho YH, Lin G, Chiu CY, Ho HY. Downregulation of NAD Kinase Expression in β-Cells Contributes to the Aging-Associated Decline in Glucose-Stimulated Insulin Secretion. Aging Cell. 2025;24(4):e70037. https://doi.org/10.1111/acel.70037
- Khavinson VK. Effect of tetrapeptide on insulin biosynthesis in rats with alloxan-induced diabetes. Bulletin of Experimental Biology and Medicine. 2005;140(4):452-454. https://doi.org/10.1007/s10517-005-0517-6
- Khavinson VKh, Gapparov MM, Sharanova NE, Vasilyev AV, Ryzhak GA. Study of biological activity of Lys-Glu-Asp-Trp-NH2 endogenous tetrapeptide. Bulletin of Experimental Biology and Medicine. 2010;149(3):351-353. https://doi.org/10.1007/s10517-010-0944-x
- Kvetnoi IM, Ryzhak AP, Kostyuchek IN, Tafeev YA. Effect of tetrapeptide pancragene on functional morphology of the pancreas in rats with experimental diabetes mellitus. Bulletin of Experimental Biology and Medicine. 2007;143(3):368-371. https://doi.org/10.1007/s10517-007-0114-y
- Khavinson V, Linkova N, Diatlova A, Trofimova S. Peptide Regulation of Cell Differentiation. Stem Cell Reviews and Reports. 2020;16(1):118-125. https://doi.org/10.1007/s12015-019-09938-8
- Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053. https://doi.org/10.3390/molecules26227053
- Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-149. https://doi.org/10.1007/s10522-009-9249-8